4.4 Review

Acceptance- and mindfulness-based interventions for persons with psychosis: A systematic review and meta-analysis

期刊

SCHIZOPHRENIA RESEARCH
卷 215, 期 -, 页码 25-37

出版社

ELSEVIER
DOI: 10.1016/j.schres.2019.11.016

关键词

-

资金

  1. National Health and Medical Research Council of Australia
  2. CR Roper Fellowship, Fac-ulty of Medicine, Dentistry, and Health Science, the University of Melbourne, Australia

向作者/读者索取更多资源

Background: Acceptance- and mindfulness-based approaches have gained popularity in recent years. Objective: A systematic review and meta-analysis of the efficacy and safety of acceptance- and mindfulness-based therapies for persons with a psychotic or schizophrenia spectrum disorder. Methods: Following PRISMA guidelines, relevant databases were searched for published randomized controlled trials (RCTs) up to October 2018. Outcomes were severity of overall symptomatology, hospitalization, positive and negative symptoms, depression, anxiety, social functioning, quality of life, acceptance, mindfulness skills and safety of the interventions. Results: Sixteen studies comprising 1268 people with a schizophrenia spectrum disorder were included in the meta-analyses. Moderate to large effect sizes were found for overall symptomatology and hospitalization at endpoint (SMD .80,95% CI -1.31, -029 and MD 4.38, -5.58, -3.17 respectively) and follow-up (SMD 1.10, -2.09, -0.10 and MD 7.18, -8.67, - 5.68 respectively). There were significant small effects on negative symptoms (SMD .24; -0.44, -0.03), small to moderate effects for depression (SMD .47; -0.80, -0.14), social functioning (SMD .43; -0.75,-0.12) and mindfulness (SMD .51; -0.97, -0.05), moderate to large effects for acceptance (SMD .78; -1.44, -0.12), while no significant effects for positive symptoms (SMD .27; -0.65,0.00), anxiety (SMD 2.11; -4.64,0.42) or quality of life (SMD .43; -0.88,0.02). Majority of studies (75%) had low risk of bias and sensitivity analyses supported the findings. Conclusion: Acceptance- and mindfulness-based approaches appear to be effective and safe interventions for individuals with schizophrenia spectrum disorders and could be a useful extension of standard casemanagement and psychofarmacology. (C) 2019 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据